MétaCan
Menu
Back to cohort
Record W4407776434 · doi:10.7150/thno.106592

Sex- and age-specific sensitivities of the endocannabinoid system in Alzheimer's disease revealed by PET imaging with [<sup>18</sup>F]FMPEP-<i>d</i><sub>2</sub> and [<sup>18</sup>F]MAGL-2102

2025· article· en· W4407776434 on OpenAlexafffund
Anna Pees, Christopher D. Morrone, Junchao Tong, Jian Rong, Tuo Shao, Darcy Wear, Steven H. Liang, Wai Haung Yu, Neil Vasdev

Bibliographic record

VenueTheranostics · 2025
Typearticle
Languageen
FieldMedicine
TopicCannabis and Cannabinoid Research
Canadian institutionsUniversity of TorontoCentre for Addiction and Mental Health
FundersNational Institutes of HealthAzrieli FoundationCanada Research ChairsCanadian Institutes of Health ResearchCentre for Addiction and Mental Health Foundation
KeywordsEndocannabinoid systemPet imagingDiseaseAlzheimer's diseaseMedicinePositron emission tomographyInternal medicineNeuroscienceNuclear medicineBiologyReceptor

Abstract

fetched live from OpenAlex

The endocannabinoid system is a critical brain signaling pathway that is dysregulated in various brain disorders, including Alzheimer's disease (AD).Cannabinoid-targeted therapies and imaging approaches have gained increasing interest; however, the biological impact of the endocannabinoid system in disease needs further validation.We aimed to study changes in cannabinoid receptor 1 (CB1) and monoacylglycerol lipase (MAGL), components of endocannabinoid signaling and degradation, in a mouse model of AD by PET imaging.Methods: [ 18 F]FMPEP-d2 and [ 18 F]MAGL-2102 were produced on a commercial radiosynthesis module.PET-CT images with both tracers were acquired in a knock-in mouse model of AD bearing mutated human amyloid precursor protein (App NL-G-F ) at 3 ages, and compared to wild-type mice.Excised brains were used for in vitro autoradiography with [ 18 F]FMPEP-d2 and [ 18 F]MAGL-2102, immunofluorescence, and western blotting.Male wild-type and 5xFAD mice were chronically treated with MAGL inhibitor JZL184 and imaged with [ 18 F]MAGL-2102 two days after ending treatment.Results: PET imaging showed sex-, age-and genotype-dependent changes in CB1 and MAGL availability.At 4-months (early-stage -amyloid pathology), female App NL-G-F mice had lower CB1 availability, and MAGL availability was increased in male App NL-G-F , compared to wild-types.At 8-months, no genotype differences in CB1 were observed, yet MAGL availability was reduced in App NL-G-F frontal cortex, and male App NL-G-F mice exhibited higher MAGL than transgenic females brain-wide.At 12-months (late-stage -amyloid pathology), significantly lower uptake of [ 18 F]FMPEP-d2 was observed in App NL-G-F compared to wild-type, with no changes in [ 18 F]MAGL-2102 binding.App NL-G-F plaque staging was confirmed by Thioflavin-S staining.Imaging findings were supplemented by autoradiography, immunofluorescence, and western blots.[ 18 F]MAGL-2102 availability was responsive to target engagement of the MAGL inhibitor JZL184 in wild-type and 5xFAD mice.Conclusions: The present study showed dynamic age-, sex-and pathology-related changes in CB1 and MAGL availability from early-stage -amyloid pathology, suggesting that the endocannabinoid system is a useful target for diagnostics and treatment of AD.Finally, these results highlight that endocannabinoid sex differences should be considered in diagnostics and drug development.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.233
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.238
Teacher spread0.228 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueTheranosticsSame topicCannabis and Cannabinoid ResearchFrench-language works237,207